Attached files
EXHIBIT 32.2
Certification
I, Lauren P. Silvernail, Chief Financial Officer and Vice President, Corporate Development of ISTA Pharmaceuticals, Inc. (the Company), certify, pursuant to Rule 13(a)-14(b) or Rule 15(d)-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, that:
(1) the Annual Report on Form 10-K of the Company for the fiscal year ended December 31, 2010 (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)); and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: February 25, 2011
/S/ LAUREN P. SILVERNAIL |
Lauren P. Silvernail, Chief Financial Officer and Vice President, Corporate Development |